logo
ResearchBunny Logo
Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy

Medicine and Health

Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy

S. Corvigno, Y. Liu, et al.

This exciting research showcases the development of a hybrid exosomal polymeric system (HEXPO) using plant-derived vesicles, promising a breakthrough in cancer therapy by effectively delivering small RNAs. The study, led by a team of experts including Sara Corvigno and Anil K. Sood, highlights the anti-angiogenic potential of miR146a in combating cancer.

00:00
00:00
Playback language: English
Abstract
Small RNAs (miRNAs or siRNAs) are effective tools for cancer therapy, but existing carriers have limitations. Plant-derived vesicles (PDVs) offer promise as RNA carriers, but issues like insufficient loading and scalability remain. This study developed a hybrid exosomal polymeric system (HEXPO) using watermelon PDVs and a dendrimer bound to miRNA146 mimic. In vivo experiments demonstrated therapeutic efficacy and revealed miR146a's anti-angiogenic activity.
Publisher
npj Precision Oncology
Published On
Apr 06, 2024
Authors
Sara Corvigno, Yuan Liu, Emine Bayraktar, Elaine Stur, Nazende Nur Bayram, Adrian Lankenau Ahumada, Supriya Nagaraju, Cristian Rodriguez-Aguayo, Hu Chen, Thanh Chung Vu, Yunfei Wen, Han Liang, Li Zhao, Sanghoon Lee, Gabriel Lopez-Berestein, Anil K. Sood
Tags
small RNAs
cancer therapy
plant-derived vesicles
exosomal system
miRNA146 mimic
therapeutic efficacy
anti-angiogenic activity
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny